SK bioscience

본문바로가기

KOR ENG

sitemap

PR

SK bioscience company news updates

Press Releases

SK bioscience´s Shingles Vaccine Sales Exceed 1 Million Doses Two Years After Launch

2020. 03. 12
SK bioscience Initiates Development of New Vaccine Platform Against Vartiants in Response to New Infectious Diseases

2020. 02. 24
SK bioscience Receives WHO PQ of Cell Culture-Based Quadrivalent Influenza Vaccine

2020. 01. 02
SK bioscience’s Varicella Vaccine Obtains World’s 2nd WHO PQ Certification

2019. 12. 11
SK bioscience Wins the 2019 Medical Korea Grand Prize

2019. 11. 21
SK bioscience´s Influenza Vaccine Receives The First Place in Vaccine Category of ‘2019 Korea Highest Brand.’

2019. 10. 30
SK bioscience Won the Andong Mayor`s Award for Contributing Social Value Connected With the Region

2019. 10. 30
SK bioscience Exports Cell Culture-Based Influenza Vaccine to Asia

2019. 09. 17
SK bioscience Begins Shipment of Cell Culture-Based Influenza Vaccine

2019. 08. 30
SK bioscience Trivalent Flu Vaccine Acquires WHO PQ Certification

2019. 04. 10
SK Bioscience - Sanofi Pasteur Started Phase 1 Clinical Trials of the next generation

2018. 12. 12
SK bioscience Launched Pre-Filled Syringe Type Shingles Vaccine

2018. 11. 23